Administration of Nifedipine CR Immediately after Awakening Prevents a Morning Surge in Hypertensive Patients. Case Report of Three Cases

References

• Graney WF. Clinical experience with a once-daily, ex-tended-release formulation of diltiazem in the treatment of hypertension. Am J Med 1992; 93: 56–64S.
   Google Scholar
• Grandinetti 0, Feraco E. Middle term evaluation of amlodipine vs nitrendipine: efficacy, safety and metabolic effects in elderly hypertensive patients. Clin Exp Hypertens 1993; 15 Suppl 1: 197–210.
   Google Scholar
• Skoularigis J, Weinberg J, Strugo V. et al. Effect of isradipine in black patients with very severe hypertension. 24-hour ambulatory blood pressure monitoring and echo-cardiographic evaluation. Am J Hypertens 1994; 7: 1058–64.
   Google Scholar
• Manion JM, Baguet JP, Boutelant S, Tremel F, Siche JP, de Gaudemaris R. Second-generation calcium antagonists and ambulatory blood pressure monitoring. J Cardiovasc Pharmacol 1995; 25 Suppl 3: S17–22.
   Google Scholar
• Zidek W, Spiecker C, Knaup G, Steindl L, Breuer HW. Comparison of the efficacy and safety of nifedipine coat-core versus amlodipine in the treatment of patients with mild-to-moderate essential hypertension. Hypertension Study Group. Clin Ther 1995; 17: 686–700.
   Google Scholar
• Podjarny E, Korzets Z, Bernheim J. Efficacy of low felodipine dose monotherapy in mild-to-moderate hyperten-sion: a comparison between office and ambulatory blood pressure monitoring. J Hum Hypertens 1996; 10 Suppl 3: S153–6.
   Google Scholar
• Ostergren J, Isaksson H, Brodin U, Schwan A, Ohman K. Effect of amlodipine versus felodipine extended release on 24-hour ambulatory blood pressure in hypertension. Am J Hypertens 1998; 11(6 Pt 1): 690–6.
   Google Scholar
• Yoshikawa H, Ohta A, Kasamatsu K, et al. Enhanced efficacy of nilvadipine in hypertensives whose raised ambulatory blood pressure is sustained during sleep. Am J Hypertens 1998; 11(1 Pt 1): 122–4.
   Google Scholar
• Tallian KB, Nahata MC, Turman MA, Mahan JD, Hayes JR, Mentser MI. Efficacy of amlodipine in pediatric patients with hypertension. Pediatr Nephrol 1999; 13: 304–10.
   PubMed Web of Science ®Google Scholar
• Fogari R, Zoppi A, Mugellini A, Preti P, Corradi L, Lusardi P. Effect of low-dose manidipine on ambulatory blood pressure in very elderly hypertensives. Cardiovasc Drugs Ther 1999; 13: 243–8.
   PubMed Web of Science ®Google Scholar
• Nold G, Herholz C, Sturm M, Hopf R, Lemmer B. Ambulatory blood pressure profiles in essential hyperten-sives after treatment with a new once daily nifedipine formulation. J Hum Hypertens 1999; 13: 173–7.
   Google Scholar
• Biston P, Melot C, Degaute JP, Clement D, Quoidbach A. Prolonged antihypertensive effect of amlodipine: a prospec-tive double-blind randomized study. Blood Press 1999; 8: 43–8.
   Google Scholar
• Pannarale G, Puddu PE, Monti F, et al. Twenty-four-hour antihypertensive efficacy of felodipine 10 mg extended-release: the Italian inter-university study. J Cardiovasc Pharmacol 1996; 27: 255–61.
   PubMedGoogle Scholar
• Cummings DM, Amadio P, Nelson L, Fitzgerald JM. The role of calcium channel blockers in the treatment of essential hypertension. Arch Intern Med 1991; 151: 250–9.
   PubMed Web of Science ®Google Scholar
• Meyers MG, Toal CB. on behalf of the Switch Study Investigators. Comparative efficacy of two long-acting formulations of nifedipine in the treatment of hypertension. Can J Cardiol 1995; 11: 913–17.
   Google Scholar
• Rahima-Maoz C, Grossman E, Nussinovitch N, Katz A, Rosenthal T. Nifedipine GITS replacing nifedipine SR: ambulatory blood pressure assessment of efficacy. Cardiol-ogy 1997; 88 Suppl 3: 43–6.
   Google Scholar
• Nakamichi N, Yanagida T, Hikima Y, etal. Phase I study of nifedipine sustained-release formulation (BAY a 1040-OD Tablets): single administration study. Jpn Pharmacol Ther 1995; 23: 7–21 (in Japanese).
   Google Scholar
• Nakamichi N, Yanagida T, Hikima Y, etal. Phase I study of nifedipine sustained-release formulation (BAY a 1040-OD Tablets): multiple administration study. Jpn Pharmacol Ther 1995; 23: 23–35 (in Japanese).
   Google Scholar
• Ichihashi H. Formulation design nifedipine sustained-release tablets (Adalat CR tablet) based on coat-core technology of hydrophilic-matrix. Membrane 2000; 25: 60–6.
   Google Scholar
• Nold G, Strobel G, Lemmer B. Morning versus evening amlodipine treatment: effect on circadian blood pressure profile in essential hypertensive patients. Blood Press Monit 1998; 3: 17–25.
   Google Scholar
• White WB. Ambulatory blood pressure monitoring: dippers compared with non-dippers. Blood Press Monit 2000; 5 Suppl 1: S17–23.
   Google Scholar
• DeQuattro V, Lee DD, Allen J, Sirgo M, Plachetka J. Labetalol blunts morning pressor surge in systolic hyperten-sion. Hypertension 1988; 11(2 Pt 2): 1198–201.
   Google Scholar
• Weber MA. The 24-hour blood pressure pattern: does it have implications for morbidity and mortality? Am J Cardiol 2002; 89: 27-33A.
   Google Scholar
• Grossman E, Messerli FH. Effect of calcium antagonists on sympathetic activity. Eur Heart J 1998; 19 Suppl F: F27–31.
   Google Scholar
• Nakamura T, Honma H, Kohno I, Tsuruta I, Ishii H, Tamura K. Efficacy of manidipine on circadian blood pressure in essential hypertension. Blood Press 1992; 3 Suppl: 94–101.
   Google Scholar
• Can AA, Bottini PB, Prisant LM, et al. Effectiveness of once-daily monotherapy with a new nifedipine sustained release calcium antagonist. Am J Cardiol 1992; 69: 28–32E.
   PubMedGoogle Scholar
• Feig PU, Gibson L, MacCarthy EP, Pettis PP, Schwartz L. The efficacy and safety of once-daily nifedipine coat-core in the treatment of mild-to-moderate hypertension. Adalat CC Cooperative Study Group. Clin Ther 1993; 15: 963–75.
   Google Scholar
• Greminger P, Suter PM, Holm D, Kobelt R, Vetter W. Morning versus evening administration of nifedipine gastrointestinal therapeutic system in the management of essential hypertension. Clin Investig 1994; 72: 864–9.
   Google Scholar
• Zanchetti A. The 24-hour efficacy of a new once-daily formulation of nifedipine. Italian Nifedipine GITS Study Group. Drugs 1994; 48 Suppl 1: 23–30.
   Google Scholar
• Zanchetti A. Trough:peak ratio of the blood pressure response to dihydropyridine calcium antagonists. Italian Nifedipine GITS Study Group. J Hypertens 1994; 12 Suppl: S97–106.
   Google Scholar